![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
References
- Katlama C, Deeks SG, Autran B, et al. Barriers to a cure for HIV: new ways to target and eradicate HIV-1 reservoirs. Lancet 2013;381:2109-17
- Saksena NK, Wang B, Zhou L, et al. HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites. HIV AIDS (Auckl) 2010;2:103-22
- Rao KS, Ghorpade A, Labhasetwar V. Targeting anti-HIV drugs to the CNS. Expert Opin Drug Deliv 2009;6:771-84
- Spudich S, Gonzalez-Scarano F. HIV-1-related central nervous system disease: current issues in pathogenesis, diagnosis, and treatment. Cold Spring Harb Perspect Med 2012;2:a007120
- Archin NM, Vaidya NK, Kuruc JD, et al. Immediate antiviral therapy appears to restrict resting CD4+ cell HIV-1 infection without accelerating the decay of latent infection. Proc Natl Acad Sci USA 2012;109:9523-8
- Henrich T. Challenges and strategies towards functional cure: how low do you need to go? 6th International Workshop on HIV Persistence during Therapy; Miami, FL;2013
- Eyal N, Kuritzkes DR. Challenges in clinical trial design for HIV-1 cure research. Lancet 2013;382:1464-5
- Denton PW, Long JM, Wietgrefe SW, et al. Targeted cytotoxic therapy kills persisting HIV infected cells during ART. PLoS Pathog 2014;10:e1003872
- Berger EA, Pastan I. Immunotoxin complementation of HAART to deplete persisting HIV-infected cell reservoirs. PLoS Pathog 2010;6(6):e1000803
- Dadachova E, Patel MC, Toussi S, et al. Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins. PLoS Med 2006;3:e427
- Bryan RA, Guimaraes AJ, Hopcraft S, et al. Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigens. Mycopathologia 2012;173:463-71
- Rivera J, Morgenstern A, Bruchertseifer F, et al. Microbicidal power of alpha radiation in sterilizing germinating Bacillus anthracis spores. Antimicrob Agents Chemother 2014;58(3):1813-15
- Dadachova E, Casadevall A. Radioimmunotherapy of infectious diseases. Semin Nucl Med 2009;39:146-53
- Hutter G, Zaia JA. Allogeneic haematopoietic stem cell transplantation in patients with human immunodeficiency virus: the experiences of more than 25 years. Clin Exp Immunol 2011;163:284-95
- Dadachova E, Kitchen SG, Bristol G, et al. Pre-clinical evaluation of a 213Bi-labeled 2556 antibody to HIV-1 gp41 glycoprotein in HIV-1 mouse models as a reagent for HIV eradication. PLoS ONE 2012;7:e31866
- Tsukrov D MA, Kitchen SG, Gorny MK, et al. Targeting HIV with radioimmunotherapy and antiretroviral drugs. Clinical and Translational Science Award Symposium; Bronx, NY; 2013
- McFarren A TD, Eugenin E, Morgenstern A, et al. A radiolabeled monoclonal antibody to gp41 eliminates HIV-1 infected monocytes after passing through a blood brain barrier model. 20th Conference on Retroviruses and Opportunistic Infections; Atlanta, GA; 2013
- Hunger SP, Lu X, Devidas M, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children’s oncology group. J Clin Oncol 2012;30(14):1663-9